Marcondes Felippe O, Dean Katie M, Schoen Robert E, Leffler Daniel A, Rose Sherri, Morris Michele, Mehrotra Ateev
The University of Texas Medical Branch at Galveston, Galveston, Texas.
Harvard Medical School, Boston, Massachusetts.
Gastrointest Endosc. 2015 Oct;82(4):668-75. doi: 10.1016/j.gie.2014.12.056.
The adenoma detection rate (ADR) is a validated and widely used measure of colonoscopy quality. There is uncertainty in the published literature as to which colonoscopy examinations should be excluded when measuring a physician's ADR.
To examine the impact of varying the colonoscopy exclusion criteria on physician ADR.
We applied different exclusion criteria used in 30 previous studies to a dataset of endoscopy and pathology reports. Under each exclusion criterion, we calculated physician ADR.
A private practice colonoscopy center affiliated with the University of Illinois College of Medicine.
Data on 20,040 colonoscopy examinations performed by 11 gastroenterologists from July 2009 to May 2013 and associated pathology notes.
ADRs across all colonoscopy examinations, each physician's ADR, and ADR ranking.
There were 28 different exclusion criteria used when measuring the ADR. Each study used a different combination of these exclusion criteria. The proportion of all colonoscopy examinations in the dataset excluded under these combinations of exclusion criteria ranged from 0% to 92.2%. The mean ADR across all colonoscopy examinations was 39.1%. The change in mean ADR after applying the 28 exclusion criteria ranged from -5.5 to +3.0 percentage points. However, the exclusion criteria affected each physician's ADR relatively equally, and therefore physicians' rankings via the ADR were stable.
ADR assessment was limited to a single private endoscopy center.
There is wide variation in the exclusion criteria used when measuring the ADR. Although these exclusion criteria can affect overall ADRs, the relative rankings of physicians by ADR were stable. A consensus definition of which exclusion criteria are applied when measuring ADR is needed.
腺瘤检出率(ADR)是一种经过验证且广泛应用的结肠镜检查质量衡量指标。在已发表的文献中,对于在测量医生的ADR时应排除哪些结肠镜检查存在不确定性。
探讨改变结肠镜检查排除标准对医生ADR的影响。
我们将之前30项研究中使用的不同排除标准应用于一个内镜检查和病理报告数据集。在每个排除标准下,我们计算医生的ADR。
一家隶属于伊利诺伊大学医学院的私人执业结肠镜检查中心。
2009年7月至2013年5月11位胃肠病学家进行的20040例结肠镜检查数据及相关病理记录。
所有结肠镜检查的ADR、每位医生的ADR以及ADR排名。
在测量ADR时使用了28种不同的排除标准。每项研究使用了这些排除标准的不同组合。在这些排除标准组合下,数据集中被排除的所有结肠镜检查的比例从0%到92.2%不等。所有结肠镜检查的平均ADR为39.1%。应用这28种排除标准后,平均ADR的变化范围为-5.5至+3.0个百分点。然而,排除标准对每位医生的ADR影响相对均等,因此通过ADR得出的医生排名是稳定的。
ADR评估仅限于单个私人内镜检查中心。
在测量ADR时使用的排除标准存在很大差异。尽管这些排除标准会影响总体ADR,但按ADR对医生进行的相对排名是稳定的。需要对测量ADR时应用哪些排除标准达成共识定义。